Anticoagulation therapy in Italy

Thromboembolic disorders are a leading cause of morbidity and mortality, affecting millions of people worldwide. A prompt instrumental and laboratory diagnosis of clinical events associated with thrombotic pathology, together with the clinical and laboratory surveillance of antithrombotic therapies are essential mechanisms for the correct management of patients with thrombosis impacting positively on their quality of life. In this review, the author will summarize the current organization of anticoagulant therapy in Italy, a country where thrombosis represents a significant health problem of great social relevance.